Therapeutic activation of HIF-1α signaling and HIF-1α/FoxM1-dependent vascular repair therefore represents a putative therapeutic strategy for the treatment of inflammatory vascular diseases, such as sepsis and ARDS. The gene discussed is FOXM1; the disease is acute respiratory distress syndrome.